Stay updated on Immunologic Response to Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page
- Check7 days agoChange DetectedThe footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check14 days agoChange DetectedThe ClinicalTrials.gov site footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check34 days agoChange DetectedThe record history shows a new revision entry (v3.7.0) replacing the previous revision (v3.6.6), indicating an updated version of the record.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry v3.6.6 was added to the study record history. The previous revision v3.6.5 was removed from the latest history view.SummaryDifference0.1%

- Check77 days agoChange DetectedThe study record history now includes a new revision entry (v3.6.5) replacing the previous v3.6.4, indicating a minor update to the page's revision metadata.SummaryDifference0.1%

- Check91 days agoChange DetectedA new revision entry labeled v3.6.4 was added to the study's record history, signaling an updated version of the record that supersedes v3.6.3. This reflects an administrative update to the record rather than substantive changes to study details.SummaryDifference0.1%

Stay in the know with updates to Immunologic Response to Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunologic Response to Pembrolizumab in Melanoma Clinical Trial page.